UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 231.20
+5.00 (2.21%)
Apr 30, 2026, 5:39 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €44.01 billion as of May 1, 2026. Its market cap has increased by 65.18% in one year.
Market Cap
44.01B
Enterprise Value
43.89B
Revenue
7.74B
Ranking
n/a
PE Ratio
28.79
Stock Price
€231.20
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 44.01B, an increase of 4,841.42%. That is a compound annual growth rate of 13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 44.01B | -2.92% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 41.54B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.25M |
| Hyloris Pharmaceuticals | 147.84M |
| European Medical Solutions | 20.91M |
| Celyad Oncology | 13.92M |
| BioSenic | 1.44M |
| Oxurion NV | 354.77K |